Thomas Charles Reilly

CIK 1827590 · EVP and CFO · last filed 2024-07-01

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.44M

Companies

2

Total Filings

16

Lifetime Open-Market Net

-$51.4K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AMRN EVP and CFO 94,305 $15.24 $1.44M $0 10 2024-07-01
Tvardi Therapeutics, Inc. (CARA) Delisted Chief Financial Officer 37,811 $15.96 $603.5K -$51.4K 6 2022-03-04

Recent Filings · Page 2 of 2

16 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-03-04 Tvardi Therapeutics, Inc. (CARA) Delisted Sell (S) −2,044 -$23.3K EDGAR
2022-03-01 Tvardi Therapeutics, Inc. (CARA) Delisted Grant (A) +25,333 $54.9K EDGAR
2021-12-21 Tvardi Therapeutics, Inc. (CARA) Delisted Grant (A) +11,170 $0 EDGAR
2021-09-01 Tvardi Therapeutics, Inc. (CARA) Delisted Sell (S) −1,982 -$28.1K EDGAR
2021-08-26 Tvardi Therapeutics, Inc. (CARA) Delisted Grant (A) +5,334 $0 EDGAR
2020-10-07 Tvardi Therapeutics, Inc. (CARA) Delisted Grant (A) $0 EDGAR
Showing 1116 of 16
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.